Description: Cresco Labs Inc. manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products. The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews. It sells its products under the Cresco brand. The company was formerly known as Cresco Labs, LLC and changed its name to Cresco Labs Inc. in November 2018. Cresco Labs Inc. is headquartered in Chicago, Illinois.
Home Page: www.crescolabs.com
400 West Erie Street
Chicago,
IL
60654
United States
Phone:
312 929 0993
Officers
| Name | Title |
|---|---|
| Mr. Thomas J. Manning | Exec. Chairman |
| Mr. Charles Bachtell | Co-Founder, CEO & Director |
| Mr. Robert M. Sampson | Co-Founder & Independent Director |
| Mr. Dennis M. Olis | Chief Financial Officer |
| Mr. Ty Gent | Chief Operating Officer |
| Ms. Brenna Albert CPA | Sr. VP and Controller of Accounting, Treasury & Tax |
| Mr. Zach Marburger | Interim Chief Information Officer |
| Jake Graves | Mang. of Investor Relations |
| Mr. John Schetz | Gen. Counsel |
| Ms. Impola Kelli | VP of Compliance |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| Forward PE: | 113.6364 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.946 |
| Price-to-Sales TTM: | 0.8311 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3300 |